Target intelligence / Profile preview

Ferritin light chain pseudogene 2 (FTLP2)

Target: FTLP2
Molecular classification: Other (pseudogene)

Overview

Ferritin light chain pseudogene 2 (FTLP2) is a non-coding pseudogene related to the *ferritin light chain (FTL)* gene. It is not transcribed into a protein and has no known biological function or disease association. The functional parent gene, FTL, encodes a key subunit of cellular ferritin, which maintains iron homeostasis, but FTLP2 itself is not a valid therapeutic or research target[1][2][3][4].

Beyond the preview

Go deeper on Ferritin light chain pseudogene 2 (FTLP2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ferritin light chain pseudogene 2 (FTLP2).

Explore the full profile